Nyxoah S.A.

Healthcare

NASDAQ:NYXH · NASDAQ Global Market

Market Cap $63.37M Beta 0.89 P/E (TTM) -0.7

$1.60 +1.25%

+$0.02 today

52W Low $1.26High $8.59

Vol 0.28M · Avg 0.22M

EPS (TTM) -$1.99Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-79.57%

Period High

$8.28

Period Low

$1.31

Latest

$1.60

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Genfit S.A.

GNFT

$445.68M

Prenetics Global Limited

NASDAQ:PRE

$342.08M

OraSure Technologies, Inc.

NASDAQ:OSUR

$299.15M

OmniAb, Inc.

NASDAQ:OABI

$266.67M

Perspective Therapeutics, Inc.

AMEX:CATX

$236.77M

Utah Medical Products, Inc.

NASDAQ:UTMD

$213.46M

KORU Medical Systems, Inc.

NASDAQ:KRMD

$183.27M

Protara Therapeutics, Inc.

NASDAQ:TARA

$155.26M

Invivyd, Inc.

NASDAQ:IVVD

$124.41M

Neuronetics, Inc.

NASDAQ:STIM

$85.19M

What is the latest NYXH filing?

The latest filing shown is SC 13D/A dated Jun 11, 2026.

How many recent filings does NYXH have?

Intrinsic Alpha currently shows 20 recent filings for NYXH.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.